Life Science News

RSS

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

Researchers from Japan's Osaka University have made an important leap in our understanding of how chronic pain conditions develop.

20 Aug 2019

New tissue clearing kits and reagents for faster, accurate 3D imaging

Abcam's tissue clearing kits and reagents enable easy and rapid clearing for 3D imaging of tissues and cell culture models.

From Abcam 20 Aug 2019

NanoString and Abcam enter commercial partnership to provide expanded menu of antibodies for GeoMx Digital Spatial Profiler

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced a commercial agreement with Abcam plc, a global innovator in life science reagents and tools, for the manufacture and sale of antibodies specifically for use with NanoString’s new GeoMx Digital Spatial Profiler.

From Abcam 20 Aug 2019

Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging

Abcam, a global innovator in life science reagents and tools, and Visikol, a contract research organization focused on advancing drug discovery, have announced a collaboration to develop new reagents and kits for improved tissue clearing and 3D imaging.

From Abcam 20 Aug 2019

Placing students at the heart of Albumedix

Recently, Albumedix were fortunate enough to employ two postgraduates through the University of Nottingham postgraduate placements scheme. The scheme places talented post-graduates with exciting companies for up to 200 hours part-time work, for between 3 - 6 months.

From Albumedix Ltd. 20 Aug 2019

Albumedix ground-breaking ceremony

May 8th marked a big day in Albumedix’s history. Holding a traditional ground-breaking ceremony; our workforce, builders and contractors all gathered to watch Peter Rosholm (Chief Executive Officer) and Stuart Woodward (Chief Manufacturing Officer) take the first official step towards the company’s expansion.

From Albumedix Ltd. 20 Aug 2019

Albumedix announces evaluation agreement with a top pharma collaborator

Novartis and Albumedix Ltd. have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis technology platform and associated technologies.

From Albumedix Ltd. 20 Aug 2019

Mini kidneys grown in the lab could be used to better understand kidney diseases

An international team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has grown 'miniature kidneys' in the laboratory that could be used to better understand how kidney diseases develop in individual patients.

20 Aug 2019

Multiple users in a Class II Biosafety Cabinet

This is an age old question that comes every now and then. First in reference from the BMBL (Biosafety in Microbiological and Biomedical Laboratories), a clear 12-inches (305 mm) should be present for separation of materials whether clean to dirty or between two users.

From NuAire 20 Aug 2019

Biosafety cabinet selection, installation, lifespan and decommissioning

NSF International published Annex E to Biosafety Cabinetry (BSC) Standard NSF/ANSI 49.

From NuAire 20 Aug 2019

NuAire now a supplier of E&I Cooperative Services

Minnesota-based producer of laboratory equipment, NuAire, today announced a new partnership with E&I Cooperative Services, which makes NuAire laboratory products available to the membership of E&I at affordable prices.

From NuAire 20 Aug 2019

Using principles of mechanics and physics to identify state of individual cells

Researchers at the NYU Tandon School of Engineering have discovered a new way to identify the state of individual cells by bringing principles of mechanical engineering and physics to bear on processes that are now well understood at the macro level, but not yet at the cellular level: how stressors such as injury and disease force an organism into a new level of equilibrium -- a biological process of finding a "new normal" called allostasis.

20 Aug 2019

Researchers develop new gene editing system that could be used for anticancer immunotherapy

Dr. Mihue Jang and her group at the Center for Theragnosis of the Korea Institute of Science and Technology announced that they have developed a new gene-editing system that could be used for anticancer immunotherapy through the simultaneous suppression of proteins that interfere with the immune system expressed on the surface of lymphoma cells and activation of cytotoxic T lymphocyte, based on the results of joint research conducted with Prof. Seokmann Hong and his group at Sejong University.

20 Aug 2019